ASKA Pharmaceutical Co. Ltd. | Ownership
Companies that own ASKA Pharmaceutical Co. Ltd.
Sumitomo Mitsui Asset Management Co., Ltd.
824,900
2.7%
-444,200
0.06%
03/15/2018
Dimensional Fund Advisors LP
520,700
1.7%
-20,400
0%
04/30/2018
The Vanguard Group, Inc.
478,345
1.57%
0
0%
07/31/2018
Norges Bank Investment Management
421,400
1.38%
19,100
0%
12/31/2017
Daiwa Asset Management Co. Ltd.
404,899
1.33%
214,699
0.01%
07/31/2018
Nomura Asset Management Co., Ltd.
385,498
1.26%
5,399
0%
07/31/2018
Goldman Sachs Asset Management LP
177,500
0.57%
3,300
0%
04/30/2018
Nikko Asset Management Co., Ltd.
169,099
0.55%
-500
0%
08/20/2018
BlackRock Fund Advisors
158,700
0.52%
0
0%
09/06/2018
Quaestio Capital Management SGR SpA
126,702
0.42%
107,872
0.04%
12/31/2017
| Address |
2-5-1 Shibaura
Tokyo Tokyo 108
Japan
|
|
Employees
|
- |
| Website |
http://www.aska-pharma.co.jp |
| Updated |
07/08/2019 |
| ASKA Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceuticals,veterinary medicines,quasi-drugs,foods,and medical devices. It operates through the following business division: Research and Development. The Research and Development division provides new medicine in R&D system with a balanced combination of cutting-edge pharmaceutical technology and a long experience, to grow and expand persistently as a medium R&D company focusing on a specialized field. |
